Suzhou Zelgen Biopharmaceuticals Co. Ltd.SSE: 688266

Announcement on Actual Controller Renewing the Concerted Action Agreement

Jan 24, 2026 · Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 24, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-actual-controller-renewing-the-concerted-action-agreement-3

Release

Announcement on Actual Controller Renewing the Concerted Action Agreement

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Suzhou Zelgen Biopharmaceuticals Co. Ltd. on 6ix

Earlier from Suzhou Zelgen Biopharmaceuticals

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trials of Combination of Injectable ZG005 with Platinum-Containing Chemotherapy RegimenJan 23
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trials of Combination of Injectable ZGGS18 and Injectable ZG005 with Chemotherapy RegimenJan 16
Announcement on Voluntary Disclosure of the Approval for Market Launch of Recombinant Human Thyrotropin β for InjectionJan 9
Announcement on Conclusion of a Global Strategic Cooperation and License Option Agreement with AbbVie Regarding the Development and Commercialization Rights of ZG006Jan 1
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Dec 13, 2025

Later from Suzhou Zelgen Biopharmaceuticals

Earnings Preannouncement for 2025Jan 31
Announcement on Shareholding Reduction Plan of Shareholders, Directors and Senior Management MembersFeb 14
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Changes of Core Technical PersonnelMar 28
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleApr 3

All Suzhou Zelgen Biopharmaceuticals news releases

Follow Suzhou Zelgen Biopharmaceuticals into a list and get an email when it puts out news.

Follow Suzhou Zelgen Biopharmaceuticals